Nonadherence to Oral 6-Mercaptopurine (6MP) in a Multi-Ethnic Cohort of Children with Acute Lymphoblastic Leukemia (ALL) and Its Impact On Relapse – a Children's Oncology Group (COG) Study (AALL03N1)
Ravi Bhatia(University of Alabama at Birmingham), Mary V. Relling(St. Jude Children's Research Hospital), Lindsey Hageman(Tianjin Chengjian University), F. Lennie Wong(Tianjin Chengjian University), A. Kim Ritchey(Children's Hospital of Pittsburgh), Jacqueline Casillas(University of California, Los Angeles), Wendy Landier(University of Alabama at Birmingham), David S. Dickens(Albert Einstein College of Medicine), Leo Mascarenhas(University of Southern California), Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Cara Hanby(City of Hope), Heeyoung Kim(City of Hope), Kornegay Nancy(St. Jude Children's Research Hospital), Bruce Bostrom(Minnesota West Community & Technical College), Jane L. Meza(Children's Oncology Group), Amanda Termuhlen
Cited by 3
Related Papers
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
|New England Journal of Medicine|2009|1.2k